T1	Measurement 0 4	eGFR
T2	Value 5 15	<45 ml/min
R1	Has_value Arg1:T1 Arg2:T2	
T3	Condition 43 67	urogenital abnormalities
T4	Qualifier 17 27	structural
T5	Qualifier 32 42	functional
T6	Parsing_Error 28 31	and
*	OR T4 T5
T7	Scope 17 42	structural and functional
R2	Has_scope Arg1:T3 Arg2:T7	
T8	Observation 74 110	predispose for urogenital infections
T9	Condition 89 110	urogenital infections
R3	multi Arg1:T8 Arg2:T9	
T10	Procedure 112 139	Investigational product use
T11	Temporal 140 160	in the last 6 months
T12	Drug 162 177	SGLT2 inhibitor
T13	Drug 179 182	TZD
T14	Drug 184 198	DPP4 inhibitor
T15	Drug 203 210	GLP1 RA
T16	Temporal 215 239	within the past 6 months
R4	Has_temporal Arg1:T10 Arg2:T11	
*	OR T12 T13 T14 T15
T17	Scope 162 210	SGLT2 inhibitor, TZD, DPP4 inhibitor and GLP1 RA
R5	Has_temporal Arg1:T17 Arg2:T16	
T18	Condition 241 244	DKA
T19	Condition 245 266	Diabetic Ketoacidosis
T20	Condition 271 274	HHS
T21	Condition 275 312	Hyperosmoloar Hyperglycaemic Syndrome
R6	Subsumes Arg1:T18 Arg2:T19	
R7	Subsumes Arg1:T20 Arg2:T21	
*	OR T18 T20
T22	Temporal 314 338	within the last 6 months
T23	Scope 241 313	DKA(Diabetic Ketoacidosis) or HHS(Hyperosmoloar Hyperglycaemic Syndrome)
R8	Has_temporal Arg1:T23 Arg2:T22	
T24	Pregnancy_considerations 340 349	Pregnancy
T25	Procedure 390 416	magnetic resonance imaging
T26	Observation 363 386	major contraindications
R9	AND Arg1:T26 Arg2:T25	
T27	Device 418 436	cardiac pacemakers
T28	Condition 438 452	claustrophobia
T29	Observation 454 468	foreign bodies
T30	Device 473 498	implanted medical devices
T31	Qualifier 504 528	ferromagnetic properties
R10	Has_qualifier Arg1:T30 Arg2:T31	
T32	Condition 532 547	Liver cirrhosis
T33	Condition 549 564	Type 1 diabetes
T34	Condition 585 606	insulin insufficiency
T35	Qualifier 573 584	uncorrected
T36	Qualifier 566 572	Severe
T37	Scope 566 584	Severe uncorrected
R11	Has_scope Arg1:T34 Arg2:T37	
T38	Observation 620 634	alcohol intake
T39	Qualifier 608 619	Significant
R12	Has_qualifier Arg1:T38 Arg2:T39	
T40	Condition 636 649	HIV infection
T41	Procedure 658 688	Traditional Chinese Medication
T42	Procedure 692 713	alternative therapies
*	OR T41 T42
T43	Condition 736 757	chronic liver disease
T44	Condition 760 783;784 785	chronic viral hepatitis B
T45	Condition 760 783;788 789	chronic viral hepatitis C
*	OR T44 T45 T47 T48 T49
T46	Parsing_Error 786 787	&
T47	Condition 792 816	autoimmune liver disease
T48	Condition 818 833	hemochromatosis
T49	Condition 835 843	Wilson's
T50	Scope 760 843	chronic viral hepatitis(B & C), autoimmune liver disease, hemochromatosis, Wilson's
R13	Subsumes Arg1:T43 Arg2:T50	
T51	Drug 857 868	medications
T52	Condition 885 894	steatosis
R14	AND Arg1:T51 Arg2:T52	
T53	Drug 899 911	Methotrexate
T54	Drug 913 928	anticonvulsants
T55	Drug 930 952	antiretroviral therapy
*	OR T53 T54 T55
T56	Scope 899 952	Methotrexate, anticonvulsants, antiretroviral therapy
R15	Subsumes Arg1:T51 Arg2:T56	
T57	Condition 963 969	stroke
T58	Drug 971 986	Steroid therapy
T59	Condition 999 1008	Cushing's
T60	Qualifier 988 998	Endogenous
R16	Has_qualifier Arg1:T59 Arg2:T60	
T61	Condition 1010 1038	Familial hypertriglyceridemi
